Abstract: The disclosure provides coronavirus mRNA vaccines, including vaccines directed against spike proteins of one or more variant strains of SARS-CoV-2, as well as methods of using the vaccines.

Abstract: A control method for preparing crop nutrient solution, applied in a regulating device, obtains growth data of crops, and determines a growth state of the crops according to the growth data of the crops. The proportion of the nutrient solution required by the crops is determined according to the growth states of the crops, and the culture solution is adjusted according to the proportion of the nutrient solution. After a preset time period, updated growth state of the crops is determined. When the culture solution does not meet the proportion of the nutrient solution corresponding to the updated growth state, the culture solution is adjusted again until the culture solution meet the proportion of the nutrient solution corresponding to the growth state of the crops.

Abstract: A semiconductor structure includes a substrate, an interconnection structure disposed over the substrate and a first memory cell. The first memory cell is disposed over the substrate and embedded in dielectric layers of the interconnection structure. The first memory cell includes a first transistor and a first data storage structure. The first transistor is disposed on a first base dielectric layer and embedded in a first dielectric layer. The first data storage structure is embedded in a second dielectric layer and electrically connected to the first transistor. The first data storage structure includes a first electrode, a second electrode and a storage layer sandwiched between the first electrode and the second electrode.

Abstract: A communication node receives a first signaling, and the first signaling indicates a target identity; monitors a first PDCCH, the first PDCCH is associated with a first downlink RS resource, the first downlink RS resource is associated with a first PCI; receives a second signaling, the second signaling is used to indicate a second PCI; as a response to the behavior of receiving a second signaling, monitors a second PDCCH and discards monitoring the first PDCCH, the second PDCCH is associated with a second downlink RS resource, and the second downlink RS resource is associated with the second PCI; the first signaling comprises an RRC message; the second signaling comprises a signaling below the RRC layer; the first PDCCH uses a source identity for scrambling; the second PDCCH uses the target identity for scrambling; the source identity and the target identity are different.

Abstract: The present disclosure provides a memory device, a semiconductor device, and a method of operating a memory device. A memory device includes a memory cell, a bit line, a word line, a select transistor, a fuse element, and a heater. The bit line is connected to the memory cell. The word line is connected to the memory cell. The select transistor is disposed in the memory cell. A gate of the select transistor is connected to the word line. The fuse element is disposed in the memory cell. The fuse element is connected to the bit line and the select transistor. The heater is configured to heat the fuse element.

Abstract: A manifold for cooling server includes an inlet pipe, an outlet pipe, a plurality of first hole groups, and a plurality of second hole groups. The distance between every two adjacent first hole groups is first distance, the distance between every two adjacent second hole groups is second distance, and the first distance is not equal to the second distance. The first distance is designed for one size of server, and the second distance is designed for another size of server. When changing the size of all servers in the rack, turning manifold 100 to 180 degrees to change the first hole groups 30 to the second hole groups 40 for adapting the severs, which makes the manifold 100 adapt two different sizes of server. A rack and a data center cooling system using the manifold are also disclosed.

Abstract: A flow guiding device in an immersion-cooled chassis of a server comprises at least one deflector located above a chip on a mainboard in the chassis, each deflector comprises a first end for mounting to the mainboard above the chip and a second end inclined away from the mainboard. The first end is immersed in coolant, the second end is higher than the first end; the deflector further comprises a hollow part including multiple through holes for interrupting upward movement vapor bubbles generated by the hot chip, which reduces probability of the vapor bubbles escaping from the coolant liquid and the chassis. A liquid-cooled chassis having the flow guiding device is also disclosed.

Abstract: In a display device including unfoldable areas and a foldable area between the unfoldable areas, the display device includes: a window; a display panel under the window; a fingerprint detection sensor configured to generate signals for fingerprint recognition in a direction toward the display panel in any one of the unfoldable areas; a first support member supporting the display panel under the display panel and between the display panel and the fingerprint detection sensor; a second support member supporting the display panel under the first support member and having an opening overlapping the fingerprint detection sensor; and a reinforcing member overlapping the opening of the second support member and between the first support member and the fingerprint detection sensor, wherein the reinforcing member includes glass.

Abstract: A method of screening a patient for a degenerative neurological disorder. The method can comprise the steps of: providing a tablet computer having a touchscreen to the patient, instructing the patient to draw a plurality of shapes, wherein each shape of the plurality of shapes is of varying complexity, recording at least one drawing characteristic for each shape drawn by the patient, mathematically analyzing the at least one drawing characteristic to determine an objective rating for each shape, analyzing the objective rating for each shape using a random forest comprising a plurality of decision trees to determine an objective probability that the patient has a neurological deficit, wherein the objective probability that the patient has a neurological deficit is the percentage of the plurality of decision trees which indicate a disease state.

Abstract: Provided are mesenchymal stem cells, a preparation method therefor, and a use thereof, the mesenchymal stem cell having oxidative stress resistance by reducing or inhibiting the expression or activity level of KEAP1, which is a negative regulator of Nrf2, so as to increase the activity of Nrf2.

Abstract: A composition and use thereof. The composition comprises an active component a and an active component b; the active component a is a compound as shown in general formula A; and the active component b is at least one of compounds which have insecticidal, acaricidal or bactericidal activity and are different from the compound as shown in general formula A. The composition has the advantages of synergistic effect and expanding prevention and treatment spectrum, and can be used for preventing and treating various pests, particularly mite damage, and plant diseases caused by various fungi, bacteria, nematodes and viruses.

Abstract: An antibacterial peptide P104 and a lysin LysP53 with broad-spectrum lytic activity and applications thereof are provided. The amino acid sequence of the antibacterial peptide P104 is shown as SEQ ID NO: 1, and the gene sequence of the antibacterial peptide P104 is shown as SEQ ID NO: 3. The amino acid sequence of the lysin LysP53 is shown as SEQ ID NO: 2, and the gene sequence of the lysin LysP53 is shown as SEQ ID NO: 4. The antibacterial peptide P104 and the lysin LysP53 have lytic activity against Gram-negative bacteria, such as Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli The lysin LysP53 can be subjected to soluble expression by Escherichia coli, and the activity of the lysin is high. Therefore, they have good application prospects in the research and development of anti-infective drugs.

Abstract: Disclosed is an air microorganism enrichment device in farms, and relates to the technical field of air microorganism collection.

Abstract: The disclosure provides a method of active immunotherapy for a cancer patient, comprising administering vaccines against Globo series antigens (i.e., Globo H, SSEA-3 and SSEA-4). Specifically, the method comprises administering Globo H-CRM197 (OBI-833/821) in patients with cancer. The disclosure also provides a method of selecting a cancer patient who is suitable as treatment candidate for immunotherapy. Exemplary immune response can be characterized by reduction of the severity of disease, including but not limited to, prevention of disease, delay in onset of disease, decreased severity of symptoms, decreased morbidity and delayed mortality.

Abstract: A conveying device and a medical device. The conveying device includes a catheter mechanism and a limiting body; wherein the catheter mechanism comprises an inner tube assembly and an outer tube, and the outer tube is sleeved on the inner tube assembly and is configured to be movable along an axial direction of the inner tube assembly; the limiting body is connected to a distal outer surface of the inner tube assembly and is configured to expand or contract along a radial direction of the inner tube assembly; the conveying device is configured such that the catheter mechanism is configured to load the medical stent and to release the medical stent when the outer tube moves from distal to proximal, and the limiting body is configured to expand when the medical stent is released so as to position the medical stent in a target position.

Abstract: An applicator, a container including the applicator, and a mold for manufacturing the applicator are provided. The applicator includes a mounting portion and an application portion that are connected to each other. The application portion is provided with a first surface and a second surface that are opposite to each other. Bristles are arranged on the first surface. A recessed portion is provided on the application portion. The recessed portion communicates with the first surface, and the recessed portion is protruded from the second surface. The recessed portion is provided in the applicator. When the recessed portion passes through an inner plug, the inner plug squeezes the recessed portion, such that the cosmetic in the recessed portion flows to the bristles, and the bristles carry a large amount of the cosmetic when pulled out of the bottle.

Abstract: A nasal dilator with improved functionality by virtue of a resilient element comprised of at least three resilient bands, a first outer resilient band that is secured to run along the length of the nasal dilator truss member, a second outer resilient band that is spaced apart from the first resilient band and is secured to run along the length of the nasal dilator truss member and at least one intermediate resilient band positioned between said first and second outer resilient bands that is spaced apart from both first and second outer resilient bands and is also secured to run along the length of the nasal dilator truss member. The intermediate resilient band or bands alters the force vector characteristics of the nasal strip as a whole, thereby providing targeted spring force to a more concentrated area of the nose when in use.

Abstract: An interlocking mechanism for a seat and a back of a chair is provided. A seat body and a chair chassis are pivotally connected, and a pad plate is pivotally connected with the seat body. Thereby the pad plate is moved around a pivotal connection between itself and the seat body when users sit on the pad plate. While a front side of the pad plate is moved downward, it is inclined to an angle slowly by a pad spring connected with the pad plate. When the use is leaning on the chair back connected with the seat body, the seat body is moved backward with a pivotal connection between itself and the chair chassis. The pivotal connection between the seat body and the pad plate can push the pad plate upward so that the seat body is inclined with the chair back and the user sits more comfortably.

Abstract: The present disclosure relates to a combined pharmaceutical composition containing a CDK4/6 inhibitor and a use thereof, and specifically relates to a combined pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof and fulvestrant. The present disclosure further relates to a use of the combined pharmaceutical composition in treating breast cancer. The combined pharmaceutical composition of the present disclosure produces better therapeutic effects in reducing tumor growth or even eliminating tumors.

Abstract: The present invention relates to a food having improved flavor, nutrition and color and a method for producing the same, and more specifically, to a food having a flavor, nutrition and color similar to those of meat, the food containing either a compound selected from the group consisting of heme, porphyrins, metalloporphyrins, and porphyrin analogs, or a microorganism that produces the compound, and a method for producing the same. According to the present invention, it is possible to improve the flavor, nutrition, and color of food by producing heme and various porphyrins, metalloporphyrins, and porphyrin analogs with high efficiency by fermentation of a microbial mutant, isolating/purifying the products, and adding the isolated/purified products to food.